Anthropic's new flagship model Claude Opus 4.7 beat every benchmark we threw at it, and eats tokens like a hungry teenager.

Willard announced his departure from Alkaline Trio in an Instagram post on Monday (Feb. 2). "With everything going on, going wrong in the world right now, this may seem insignificant but it's not for ...

While Bethesda has made its position very clear on Fallout game locations (it'll never stray outside of the United States) that doesn't stop people dreaming about exploring irradiated wastelands in ...

Athletic footwear has entered a new era of ambition. No longer content to promise just comfort or performance, Nike claims its shoes can activate the brain, heighten sensory awareness and even improve ...

Artificial-intelligence workloads are pushing semiconductor design to a point where traditional scaling strategies are running out of room. Performance improvements that once came from shrinking ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

And that's what he is in this game for. Clearly he has been reading or watching a lot of Watchmen and has Doctor Manhattan envy. DC's KO: Superman Vs Captain Atom by Joshua Williamson and Sean Izaakse ...

An advanced nuclear startup just achieved a milestone as it races to meet an ambitious Department of Energy goal. Founded just over two years ago in July 2023, El Segundo-based Valar Atomics announced ...

These days, if you need to connect two devices via wire, you'll most likely use HDMI. This display protocol supports all sorts of device pairings. It lets you use your iPhone with an external display, ...

Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...